View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
August 11, 2010

BioVentrix Announces Milestone for PliCath HF System

BioVentrix has announced a first-in-man milestone for its PliCath HF System following the completion of an epicardial catheter-based ventricular reconstruction in a 52-year-old male heart patient in Krakow, Poland. BioVentrix's PliCath HF System is designed to treat heart failure by redu

By cms admin

BioVentrix has announced a first-in-man milestone for its PliCath HF System following the completion of an epicardial catheter-based ventricular reconstruction in a 52-year-old male heart patient in Krakow, Poland.

BioVentrix’s PliCath HF System is designed to treat heart failure by reducing an enlarged left ventricle using a catheter.

The patient’s heart size decreased by 40% following surgery, and the volume of blood ejected from the ventricle after contraction increased by 15%.

Jerzy Sadowski, lead surgeon at Krakow’s Pope John Paul II Hospital, said the technology allowed the surgeons to perform the major reconstruction of the left ventricle in a matter of minutes and without incisions.

“This device has great promise and should help improve the quality of life of our patients suffering from heart failure,” he said.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management